Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Internal Medicine)
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine), MRCP (UK)
Internal Medicine Specialist
MBBS, MCPS (Family Medicine), MRCGP (Medicine), FRCGP
Gastroenterologist
MBBS, MCPS, FCPS (Gastroenterology), FCPS (Medicine), MACG (USA)
Gastroenterologist
MBBS, MCPS, FCPS (Gastroenterology), FCPS (Medicine), MACG (USA)
Rheumatologist
MBBS, Diplomate American Board of Internal Medicine, Diplomate American Board of Rheumatology
Rheumatologist
MBBS, Diplomate American Board of Internal Medicine, Diplomate American Board of Rheumatology
Internal Medicine Specialist
M.B.B.S, M.D (Medicine), M.R.C.P (UK)
Internal Medicine Specialist
MBBS, MRCP (UK), FCPS( Medicine), FCPS ( Endocrinology)
Internal Medicine Specialist
MBBS, MRCP (UK), FCPS( Medicine), FCPS ( Endocrinology)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures